|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from (used in) operating activities: | |||||
| Net Income Loss | |||||
| (Income) loss from discontinued operations | |||||
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | |||||
| Depreciation expense | |||||
| Loss on trading securities | |||||
| Stock-based compensation | |||||
| Changes in operating assets and liabilities: | |||||
| Value added tax receivable, net | |||||
| Prepaid expenses and other assets | |||||
| Right-of-use assets | |||||
| Accounts payable and other accrued liabilities | |||||
| Other current liabilities | |||||
| Other long-term liabilities | |||||
| Net cash used in operating activities - continuing operations | |||||
| Net cash used in operating activities - discontinued operations | |||||
| Net cash used in operating activities | |||||
| Cash flows from (used in) investing activities: | |||||
| Proceeds from sale of assets | |||||
| Investment in Golden Gryphon | |||||
| Net cash provided by (used in) investing activities - continuing operations | |||||
| Net cash provided by investing activities - discontinued operations | |||||
| Net cash provided by investing activities | |||||
| Cash flows from (used in) financing activities: | |||||
| Proceeds from issuance of common stock, net of issuance costs | |||||
| Common stock shares relinquished to pay taxes | |||||
| Net cash (used in) provided by financing activities - continuing operations | |||||
| Net cash (used in) provided by financing activities | |||||
| Net decrease in cash and cash equivalents | |||||
| Cash, cash equivalents, and restricted cash, beginning of year | |||||
| Cash, cash equivalents, and restricted cash, end of year | |||||
| Supplemental disclosure: | |||||
| Interest paid | |||||
| Deferred equity offering costs amortized | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
| Total cash, cash equivalents, and restricted cash | |||||
Loading...